Compare with the quarter-end price of $8.56 reported in the 13F
| Recent activity | |||
|---|---|---|---|
| Samantha McLemore · Patient Capital Management | 5.2% | Reduce-5.7% | $153.7M |
| Polen Capital · Polen Capital Management | 0.1% | New | $6.0M |
Changing hands in PGEN, Q3 2026
Superinvestors sold $9.3M and bought $6.0M. 1 new position. 1 of 1 sellers had held it for 5+ years.
Dollars moved = change in shares × the quarter-end price reported in the 13F. Only superinvestors that have filed for Q3 2026.